Physician profile
Stuart I Schreiber
NPI 1255457974
$1,328.10
in general payments reported to CMS, 2019-2025
9 companies · $409 in 2025
The $409 reported for 2025 was more than what 88% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.63 · 2020: $157 · 2021: $13.96 · 2023: $123 · 2024: $553 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,059 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,059.21 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $541.95 | 2019-2025 | Invisalign, Itero |
| Dentsply Sirona INC | $487.97 | 2019-2025 | Suresmile, Waveone Gold Conform Fit, Cavitron |
| Kavo Dental Technologies LLC | $73.33 | 2020 | |
| Orapharma, A Division of Bausch Health US, LLC | $68.19 | 2023-2025 | Arestin, Ossix Plus |
| Kerr Corporation | $36.84 | 2023 | H.P. Sleeve |
| Nobel Biocare USA | $36.84 | 2023 | Nobelactive |
| Geistlich Pharma, North America, INC. | $35.25 | 2024-2025 | Biomaterials, Geistlich Bio-Gide |
| Philips North America LLC | $33.77 | 2020 | |
| 3m Company | $13.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Schreiber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.